Buys | $43,800 | 1 | 100 |
Sells | $0 | 0 | 0 |
LEPORE PATRICK G | director | 1 | $43,800 | 0 | $0 | $43,800 |
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various …
Over the last 12 months, insiders at VYNE Therapeutics Inc. have bought $43,800 and sold $0 worth of VYNE Therapeutics Inc. stock.
On average, over the past 5 years, insiders at VYNE Therapeutics Inc. have bought $5.19M and sold $5.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: LEPORE PATRICK G (director) — $43,800.
The last purchase of 15,000 shares for transaction amount of $43,800 was made by LEPORE PATRICK G (director) on 2025‑01‑15.
2025-01-15 | LEPORE PATRICK G | director | 15,000 0.106% | $2.92 | $43,800 | -11.59% | ||
2023-11-15 | LEPORE PATRICK G | director | 13,000 0.3748% | $3.91 | $50,778 | -45.75% | ||
2021-11-30 | LEPORE PATRICK G | director | 12,500 0.024% | $1.02 | $12,699 | -55.58% | ||
2021-08-25 | LEPORE PATRICK G | director | 12,500 0.0243% | $1.60 | $20,000 | -62.27% | ||
2021-08-16 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 250,000 0.4697% | $1.74 | $435,000 | -64.78% | |
2021-08-13 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 250,000 0.4967% | $1.84 | $460,000 | -64.61% | |
2021-08-12 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 338,897 0.7299% | $2.23 | $755,740 | -68.34% | |
2021-05-26 | LEPORE PATRICK G | director | 12,500 0.0241% | $3.60 | $44,958 | -68.32% | ||
2021-05-06 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 1M 2.0052% | $3.67 | $3.67M | -65.17% | |
2021-03-15 | LEPORE PATRICK G | director | 12,500 0.0259% | $7.41 | $92,563 | -79.34% | ||
2021-01-28 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 4.22M 2.2941% | $2.37 | $10M | -69.62% | ||
2020-12-03 | LEPORE PATRICK G | director | 100,000 0.078% | $1.71 | $170,850 | -46.15% | ||
2020-09-08 | Domzalski David | President and CEO | 150,000 0.084% | $1.38 | $207,135 | +10.54% | ||
2020-09-08 | Saik Andrew | Chief Financial Officer | 80,000 0.0474% | $1.46 | $116,960 | +10.54% | ||
2020-06-09 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 5.41M 3.4508% | $1.85 | $10M | -19.14% | ||
2018-07-24 | Sale | Presidio Partners 2007 GP, L.P. | 1M 4.3407% | $7.65 | $7.65M | -11.34% | ||
2018-01-25 | Remeditex Ventures LLC | 10 percent owner | 200,000 0.6735% | $17.00 | $3.4M | -71.72% | ||
2018-01-25 | venBio Global Strategic Fund II L.P. | 10 percent owner | 530,000 1.7848% | $17.00 | $9.01M | -71.72% | ||
2018-01-25 | Vivo Capital VIII, LLC | 10 percent owner | 588,236 1.9809% | $17.00 | $10M | -71.72% | ||
2018-01-25 | Cha Albert | director | 588,236 1.9809% | $17.00 | $10M | -71.72% |
LEPORE PATRICK G | director | 51472 0.3384% | $96,252.64 | 7 | 0 | <0.0001% |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 4935057 32.4463% | $9.23M | 2 | 4 | <0.0001% |
Remeditex Ventures LLC | 10 percent owner | 1582854 10.4067% | $2.96M | 1 | 0 | |
Domzalski David | President and CEO | 1315966 8.652% | $2.46M | 1 | 0 | +10.54% |
Saik Andrew | Chief Financial Officer | 340000 2.2354% | $635,800.00 | 1 | 0 | +10.54% |
$14,315,062 | 61 | -6.21% | $33.06M | |
$53,490,060 | 55 | 19.35% | $30.29M | |
$94,084,626 | 29 | -21.08% | $24.05M | |
$1,295,471 | 17 | 21.79% | $25.73M | |
$17,594,514 | 16 | -20.37% | $33.77M |
Increased Positions | 19 | +55.88% | 1M | +14.41% |
Decreased Positions | 12 | -35.29% | 646,991 | -8.8% |
New Positions | 9 | New | 939,171 | New |
Sold Out Positions | 6 | Sold Out | 514,615 | Sold Out |
Total Postitions | 41 | +20.59% | 8M | +5.61% |
Cormorant Asset Management, Lp | $2,580.00 | 9.3% | 1.39M | 0 | 0% | 2024-12-31 |
Eventide Asset Management, Llc | $2,580.00 | 9.3% | 1.39M | 0 | 0% | 2024-12-31 |
Citadel Advisors Llc | $2,276.00 | 8.2% | 1.23M | +43,044 | +3.63% | 2024-12-31 |
Dsc Advisors, L.P. | $1,288.00 | 4.64% | 696,465 | 0 | 0% | 2024-09-30 |
Vanguard Group Inc | $879.00 | 3.17% | 475,129 | +31,611 | +7.13% | 2024-12-31 |
Acorn Capital Advisors, Llc | $845.00 | 3.05% | 456,970 | +456,970 | New | 2024-12-31 |
Palo Alto Investors Lp | $824.00 | 2.97% | 445,434 | 0 | 0% | 2024-12-31 |
Exome Asset Management Llc | $654.00 | 2.36% | 353,434 | 0 | 0% | 2024-12-31 |
Oconnor, A Distinct Business Unit Of Ubs Asset Management Am | $455.00 | 1.64% | 245,800 | +245,800 | New | 2024-12-31 |
Schonfeld Strategic Advisors Llc | $327.00 | 1.18% | 176,658 | +8,058 | +4.78% | 2024-12-31 |